- Home
- BRLT vs PRPO Comparison
BRLT vs PRPO Comparison
Compare BRLT & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLT
- PRPO
- Stock Information
- Founded
- BRLT 2005
- PRPO N/A
- Country
- BRLT United States
- PRPO United States
- Employees
- BRLT N/A
- PRPO N/A
- Industry
- BRLT Consumer Specialties
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- BRLT Consumer Discretionary
- PRPO Industrials
- Exchange
- BRLT Nasdaq
- PRPO Nasdaq
- Market Cap
- BRLT 36.6M
- PRPO 32.4M
- IPO Year
- BRLT 2021
- PRPO N/A
- Fundamental
- Price
- BRLT $2.16
- PRPO $20.19
- Analyst Decision
- BRLT Hold
- PRPO
- Analyst Count
- BRLT 2
- PRPO 0
- Target Price
- BRLT $1.80
- PRPO N/A
- AVG Volume (30 Days)
- BRLT 117.3K
- PRPO 11.2K
- Earning Date
- BRLT 11-05-2025
- PRPO 11-17-2025
- Dividend Yield
- BRLT N/A
- PRPO N/A
- EPS Growth
- BRLT N/A
- PRPO N/A
- EPS
- BRLT N/A
- PRPO N/A
- Revenue
- BRLT $432,597,000.00
- PRPO $21,242,000.00
- Revenue This Year
- BRLT $5.48
- PRPO N/A
- Revenue Next Year
- BRLT $3.45
- PRPO N/A
- P/E Ratio
- BRLT N/A
- PRPO N/A
- Revenue Growth
- BRLT 1.31
- PRPO 27.05
- 52 Week Low
- BRLT $1.25
- PRPO $3.90
- 52 Week High
- BRLT $3.10
- PRPO $22.38
- Technical
- Relative Strength Index (RSI)
- BRLT 41.82
- PRPO 54.22
- Support Level
- BRLT $2.23
- PRPO $19.00
- Resistance Level
- BRLT $2.90
- PRPO $21.41
- Average True Range (ATR)
- BRLT 0.23
- PRPO 1.14
- MACD
- BRLT -0.03
- PRPO -0.14
- Stochastic Oscillator
- BRLT 6.49
- PRPO 38.35
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.